Quest Diagnostics (DGX) Treasury Shares (2009 - 2026)

Quest Diagnostics has disclosed Treasury Shares across 18 years of filings, most recently posting $5.1 billion for Q1 2026.

• Treasury Shares for Q1 2026 came in at $5.1 billion, up 6.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.1 billion (up 6.28% YoY), and the FY2025 annual result was $5.2 billion, up 6.65% from the prior year.
• Treasury Shares came in at $5.1 billion for Q1 2026 at Quest Diagnostics, down from $5.2 billion in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $95.0 million in Q2 2021 to a low of $1.0 million in Q4 2021.
• The 5-year median for Treasury Shares is $48.0 million (2022), against an average of $33.4 million.
• Peak annual rise in Treasury Shares reached 49.02% in 2022, while the deepest fall reached 43.41% in 2022.
• Quest Diagnostics' Treasury Shares stood at $4.7 billion in 2022, then gained by 3.27% to $4.8 billion in 2023, then rose by 0.64% to $4.9 billion in 2024, then grew by 6.65% to $5.2 billion in 2025, then declined by 1.72% to $5.1 billion in 2026.
• The last three Treasury Shares figures came in at $5.1 billion (Q1 2026), $5.2 billion (Q4 2025), and $4.9 billion (Q3 2025), per Business Quant data.